Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.
Palmer M, Regev A, Lindor K, Avigan MI, Dimick-Santos L, Treem W, Marcinak JF, Lewis JH, Anania FA, Seekins D, Shneider BL, Chalasani N. Palmer M, et al. Among authors: lindor k. Aliment Pharmacol Ther. 2020 Jan;51(1):90-109. doi: 10.1111/apt.15579. Epub 2019 Nov 25. Aliment Pharmacol Ther. 2020. PMID: 31762074 Free PMC article. Review.
Diagnosis and therapy of cholestatic liver disease.
Pasha TM, Lindor KD. Pasha TM, et al. Among authors: lindor kd. Med Clin North Am. 1996 Sep;80(5):995-1019. doi: 10.1016/s0025-7125(05)70477-6. Med Clin North Am. 1996. PMID: 8804372 Review.
Medical management of chronic cholestatic liver diseases.
Gossard AA, Lindor KD. Gossard AA, et al. Among authors: lindor kd. Can J Gastroenterol. 2000 Nov;14 Suppl D:93D-98D. doi: 10.1155/2000/871543. Can J Gastroenterol. 2000. PMID: 11110620 Review.
Review article: Non-alcoholic fatty liver disease.
Alba LM, Lindor K. Alba LM, et al. Among authors: lindor k. Aliment Pharmacol Ther. 2003 Apr;17(8):977-86. doi: 10.1046/j.1365-2036.2003.01493.x. Aliment Pharmacol Ther. 2003. PMID: 12694079 Review.
The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study.
Martin CR, Blanco PG, Keach JC, Petz JL, Zaman MM, Bhaskar KR, Cluette-Brown JE, Gautam S, Sheth S, Afdhal NH, Lindor KD, Freedman SD. Martin CR, et al. Among authors: lindor kd. Aliment Pharmacol Ther. 2012 Jan;35(2):255-65. doi: 10.1111/j.1365-2036.2011.04926.x. Epub 2011 Nov 30. Aliment Pharmacol Ther. 2012. PMID: 22129201 Free PMC article.
481 results